The Mississippi State Department of Health is committed to meeting the statutory requirements of the Mississippi Medical Cannabis Act. Our goal is to provide a safe and accessible program that meets the needs of patients and the public health and safety of all Mississippi residents.
MSDH is currently working to establish licensing and patient registry systems in accordance with the Mississippi Medical Cannabis Act (Senate Bill 2095)
E-mail updates about the Mississippi Medical Cannabis Program and its regulations are free.
These new regulations are available for public comment through 12:59 PM, May 20, 2022.
MSDH is developing regulations for all aspects of medical cannabis production. Some initial proposed regulations are below.
By June 2022 MSDH plans to begin accepting online license applications for:
- medical practitioners
- cannabis cultivation facilities
- cannabis processing facilities
- cannabis testing facilities
- cannabis waste disposal entities
- cannabis transportation entities
Approval times: Once the application process begins in June 2022, there will be a 30-day approval time for licensure applications, and a five-day approval time for program patients.
Dispensaries: The Mississippi Department of Revenue will be responsible for the licensing of medical cannabis dispensaries.
Documents and Forms
If a company plans to apply for licensure through the Mississippi State Department of Health for any aspect of the Mississippi Medical Cannabis Program, potential applicants should first register with the Mississippi Secretary of State's Office.
As part of this registration, entities are required to select an NAICS Code as part of their formation or registration. If the company is interested in being licensed to participate in the Medical Cannabis Program, the applicable NAICS codes are given below.
|Type of Licensure||NAICS Code|
|Transporter (local freight)||484220|
|Transporter (long distance)||484230|
Cultivation and Availability
The Mississippi Medical Cannabis Act requires that cultivation of marijuana occur indoors in secure facilities, and that these facilities must be located in Mississippi if they provide products available to those with patient identification cards.
In order to ensure that individuals participating in the program receive products that have been tested and fall within the limits set by the Mississippi Legislature, MSDH anticipates that products will become available to patients in late 2022 to allow for cultivation of marijuana in the state and safety testing.
The following medical conditions or their treatment qualify for participation in the Mississippi Medical Cannabis Program:
- Parkinson's disease
- Huntington's disease
- muscular dystrophy
- spastic quadriplegia
- positive status for human immunodeficiency virus (HIV)
- acquired immune deficiency syndrome (AIDS)
- amyotrophic lateral sclerosis (ALS)
- Crohn's disease
- ulcerative colitis
- sickle-cell anemia
- Alzheimer's disease
- agitation of dementia
- post-traumatic stress disorder (PTSD)
- pain refractory to appropriate opioid management
- diabetic/peripheral neuropathy
- spinal cord disease or severe injury
Also qualifying is a chronic terminal or debilitating disease or medical condition or its treatment that produces one or more of the following:
- cachexia or wasting syndrome
- chronic pain
- severe or intractable nausea
- severe and persistent muscle spasms including, but not limited to, those characteristic of multiple sclerosis
For inquiries about the Mississippi Medical Cannabis Program, send e-mail to MSMedicalCannabis@msdh.ms.gov